Gene therapy shows promise for functional HIV cure in monkey study
By
Jon Cohen
Summary
A gene-therapy study published in Science Translational Medicine shows promise for a 'functional cure' for HIV. Researchers delivered a gene into monkeys that produces an antibody blocking the AIDS virus. Six animals suppressed HIV after a single shot of the treatment, which works by making a cell-receptor antibody. This approach, which has long struggled to gain traction, may now have renewed momentum in the fight against HIV/AIDS.
Source
bskyGene therapy shows promise for functional HIV cure in monkey studyscience.orgKey quotes
· 3 pulledA gene-therapy approach to thwart the AIDS virus that has long struggled to gain traction may have new momentum after a study found it could 'functionally cure' at least some monkeys.
In the experiment, reported today in Science Translational Medicine, researchers delivered a gene into the animals that produces an antibody to block the virus.
Six animals suppressed AIDS virus after one shot of treatment that makes cell-receptor antibody.
You might also wanna read
Efficient mRNA delivery to resting T cells to reverse HIV latency
Seventh Person Cured of HIV Through Stem Cell Transplant, Second Without HIV-Resistant Cells
A man has become the seventh person to be cured of HIV after receiving a stem cell transplant for blood cancer treatment. Significantly, he
newscientist.com·7mo ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·10mo agoVaccination elicits HIV broadly neutralizing antibodies in primates
Challenges and approaches in developing an HIV vaccine through broadly neutralizing antibodies
This article discusses the challenges and potential approaches to developing an effective HIV vaccine. It highlights that while therapies ex
scim.ag·8d ago
FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
FDA·2mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.